| Literature DB >> 27329265 |
John Bosco Omony1,2, Agnes Wanyana1, Kizito K Mugimba1, Halid Kirunda3, Jessica Lukanga Nakavuma1, Maxwell Otim-Onapa4, Denis Karuhize Byarugaba5.
Abstract
BACKGROUND: Uganda poultry production is still faced with frequent outbreaks of Newcastle disease (ND) in the backyard free-range systems despite the accessibility of cross protective vaccines. Live bird markets and waterfowl has long been reported as a major source of disease spread as well as potential sources of avirulent strains that may mutate to virulent strains. ND-virus has been reported enzootic in Ugandan poultry but limited studies have been conducted to ascertain thermostability phenotypes of the Ugandan ND-virus strains and to understand how these relate to vaccine strains.Entities:
Keywords: HN gene; Hemagglutionation assay; Infectivity; Thermostability; Thermostable isolate
Mesh:
Substances:
Year: 2016 PMID: 27329265 PMCID: PMC4915153 DOI: 10.1186/s12985-016-0560-0
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Fig. 1Distribution of ND-virus isolates by region and species of birds. The numbers above bars indicate isolates in different regions and bird species
Thermostability profiles with numbers of NDV isolates by HA activity determined at 56 °C incubation
| Thermostability/inactivation time in min. at 56 °C | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGIONS | District | Site | 15 | 30 | 45 | 60 | 75 | 90 | 105 | 120 | All |
| Central | KALUNGU | C | – | 1 | – | 1 | – | – | – | – | 2 |
| P | – | 1 | – | 2 | 1 | – | – | – | 4 | ||
| KIBOGA | C | – | 1 | – | – | – | – | – | – | 1 | |
| P | – | 1 | – | – | – | – | – | – | 1 | ||
| LWENGO | C | 2 | – | – | – | – | – | – | – | 2 | |
| P | – | 2 | – | – | – | – | – | – | 2 | ||
| MASAKA | C | – | 1 | – | – | – | – | – | 1 | 2 | |
| P | 1 | 1 | – | – | – | – | – | – | 2 | ||
| MUKONO | P | 1 | – | – | – | – | – | – | – | 1 | |
| WAKISO | C | 2 | – | – | – | – | – | – | – | 2 | |
| East | BUGIRI | C | – | 1 | 1 | – | – | – | – | – | 2 |
| P | 1 | 1 | – | – | – | – | – | – | 2 | ||
| IGANGA | C | – | 1 | 1 | – | – | – | – | – | 2 | |
| P | – | – | – | – | – | 1 | – | – | 1 | ||
| T | – | 2 | – | – | 1 | – | – | – | 3 | ||
| MAYUGE | P | – | 1 | – | – | – | – | – | – | 1 | |
| MBALE | C | 1 | – | – | – | – | – | – | 1 | 2 | |
| P | – | 1 | – | – | – | – | – | – | 1 | ||
| North | APAC | C | 1 | – | – | – | – | – | – | – | 1 |
| ARUA | C | 2 | 1 | – | – | – | – | – | – | 3 | |
| P | 3 | – | 1 | – | – | – | – | – | 4 | ||
| KOBOKO | C | – | 2 | – | – | – | – | – | – | 2 | |
| P | – | – | 2 | 1 | 1 | – | – | – | 4 | ||
| KOLE | P | 1 | – | – | – | – | – | – | – | 1 | |
| LIRA | C | 1 | – | – | – | – | – | – | – | 1 | |
| P | 1 | – | – | – | – | – | – | – | 1 | ||
| MARACH | C | 1 | 1 | – | – | – | – | 1 | – | 3 | |
| P | – | – | 2 | – | 1 | 1 | – | – | 4 | ||
| OTUKE | C | – | – | 1 | – | – | – | – | – | 1 | |
| OYAM | C | 5 | 1 | – | – | – | 1 | – | 2 | 9 | |
| P | 7 | 1 | 2 | – | 1 | – | – | 2 | 13 | ||
| YUMBE | C | 1 | – | – | – | – | – | – | – | 1 | |
| P | 2 | – | – | – | – | – | – | 1 | 3 | ||
| ZOMBO | C | 3 | 1 | – | 1 | – | 1 | – | – | 6 | |
| P | – | – | 1 | – | – | – | – | – | 1 | ||
| North-East | ABIM | C | – | 1 | – | 2 | – | – | – | 1 | 4 |
| P | – | 1 | – | – | – | – | – | 1 | 2 | ||
| KOTIDO | C | – | 1 | – | – | – | – | – | – | 1 | |
| P | 2 | – | – | – | – | – | – | – | 2 | ||
| KUMI | C | – | – | – | – | – | – | – | 1 | 1 | |
| P | – | – | 1 | 1 | 2 | – | – | – | 4 | ||
| NAMUTUMBA | C | – | 1 | – | 1 | 1 | – | – | – | 3 | |
| SERERE | P | – | 1 | – | – | – | – | – | – | 1 | |
| Western | BUNDIBUJO | C | – | – | 1 | – | – | – | – | 1 | 2 |
| KABALE | P | – | 1 | – | – | – | – | – | – | 1 | |
| KABAROLE | C | 1 | – | – | – | – | – | – | – | 1 | |
| KASESE | F | 1 | – | – | – | 1 | – | 1 | 2 | 5 | |
| P | – | – | 1 | – | – | – | – | – | 1 | ||
| KYENJOJO | P | – | 1 | – | – | – | – | – | – | 1 | |
| MBARARA | P | – | 1 | – | – | – | – | – | – | 1 | |
| Waterfowl | JINJA | F | 2 | 1 | – | – | – | – | 1 | 2 | 6 |
| RAKAI | F | 10 | 1 | 1 | – | – | – | – | 3 | 15 | |
| WAKISO | F | 8 | 5 | 3 | 1 | – | 2 | 1 | 5 | 25 | |
| Number of Isolates | 60 | 38 | 18 | 10 | 9 | 6 | 4 | 23 | 168 | ||
Hemagglutination titers and heat inactivation rate constant (k) of thermostable ND-viruses incubated at 56 °C
| Arithmetic mean HA titer (log2) at various time intervals of heat inactivation (minutes) | Rate constant (k) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Virus Isolates | 0 | 15 | 30 | 45 | 60 | 75 | 90 | 105 | 120 | (103 K/min−1) |
| NDV007/UG/MU/2011 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 2.23 |
| NDV015/UG/MU/2011 | 6 | 6 | 6 | 6 | 5 | 5 | 4 | 4 | 4 | 4.26 |
| NDV022/UG/MU/2011 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 3 | 4.36 |
| NDV023/UG/MU/2011 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 3 | 1 | 12.62 |
| NDV039/UG/MU/2011 | 8 | 8 | 8 | 8 | 7 | 7 | 6 | 5 | 4 | 5.44 |
| NDV059/UG/MU/2011 | 8 | 8 | 7 | 7 | 6 | 6 | 5 | 4 | 3 | 7.59 |
| NDV073/UG/MU/2011 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 2 | 1 | 11.59 |
| NDV089/UG/MU/2011 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 9.45 |
| NDV092/UG/MU/2011 | 5 | 5 | 4 | 3 | 2 | 2 | 2 | 1 | 1 | 14.51 |
| NDV097/UG/MU/2011 | 8 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3.08 |
| NDV098/UG/MU/2011 | 5 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 8.38 |
| NDV099/UG/MU/2011 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 1 | 9.82 |
| NDV111/UG/MU/2011 | 6 | 5 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 10.25 |
| NDV115/UG/MU/2011 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 4 | 1.80 |
| NDV118/UG/MU/2011 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 0.00b |
| NDV119/UG/MU/2011 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 2 | 6.52 |
| NDV133/UG/MU/2011 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 0.00b |
| NDV152/UG/MU/2011 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 0.00b |
| NDV158/UG/MU/2011 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 7.51 |
| NDV173/UG/MU/2011 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 0.81b |
| NDV177/UG/MU/2011 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 1.22b |
| NDV178/UG/MU/2011 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 4 | 0.81b |
| NDV180/UG/MU/2011 | 6 | 6 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | 6.54 |
|
| 11 | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 1.24a |
|
| 8 | ≥1 | – | – | – | – | – | – | – | 245.97a |
aReference vaccines
bMost thermostable ND-virus, below I2 reference thermostable strain
Fig. 2In vitro HA stability test of indicated thermostable field ND-virus at different time intervals. Incubation at 56 °C revealed loss of titer for isolates after 120 min (a–d). Thermostable I2 (e) and thermolabile LaSota (f) reference strains were included as controls. Values were averages of two independent tests (Mean ± SD, n = 2)
Fig. 3Stability of infectivity of indicated ND-virus strains by geometric mean log10EID50% following serial passages. A greater change in the titers of field strains occurred at 4th and 5th passages compared to I2 reference vaccine. LaSota, a thermolabile vaccine was unheated initially but included to compare its viability with that of thermostable isolates. Values indicated are means of three independent tests (Mean ± SD, n = 3)
HA and infectivity titers of avirulent, thermostable ND-viruses at 56 °C for 0, 30, 60 min
| Virus | Parameter | Heat treatment time (minutes.) at 56 °C | ||
|---|---|---|---|---|
| 0 | 30 | 60 | ||
| NDV133/UG/MU/2011 | aHA titer (log2) | 26 | 26 | 26 |
| bInfectivity titer | 108.53 | 108.35 | 108.05 | |
| NDV173/UG/MU/2011 | aHA titer (log2) | 26 | 26 | 26 |
| bInfectivity titer | 108.4 | 108.25 | 107.7 | |
| NDV177/UG/MU/2011 | aHA titer (log2) | 26 | 26 | 26 |
| bInfectivity titer | 107.3 | 106.3 | 102.25 | |
| NDV178/UG/MU/2011 | aHA titer (log2) | 26 | 26 | 26 |
| bInfectivity titer | 107.8 | 106.45 | 106.2 | |
| I2 thermostable strain | aHA titer (log2) | 211 | 210 | 210 |
| bInfectivity titer | 109.8 | 109.5 | 109.3 | |
| LaSota thermolabile | aHA titer (log2) | 29 | 29 | 29 |
| bInfectivity titer | 109.6 | – | – | |
aHemagglutination assay (HA) titer presented as arithmetic mean HA log2 titer; and infectivity as log10
b50 % embryonated egg infectious dose (EID50/ml)
Predicted transmembrane amino acid sequences analysis for HN gene of thermostable ND-viruses and vaccine strains
|
| |||||
|---|---|---|---|---|---|
| NDV strain | Start | End | Cutoff | Length | Predicted amino acid sequence |
| NDV/UG/MU/007 | 24 | 47 | 1.7 | 24 | VFRIAVLSLIIMILVISVSILVYS |
| 25 | 46 | 2.2a | 22 |
| |
| 96 | 97 | 1.7 | 2 | LL | |
| 101 | 105 | 1.7 | 5 | STIMN | |
| 557 | 563 | 1.7 | 7 | RIVPLLV | |
| NDV/UG/MU/098 | 24 | 47 | 1.7 | 24 | VFRIAVLSLIIMILVISVSILVYS |
| 25 | 46 | 2.2a | 22 | FRIAVLSLIIMILVISVSILV | |
| 96 | 97 | 1.7 | 2 | LL | |
| 101 | 104 | 1.7 | 4 | SVIM | |
| 557 | 563 | 1.7 | 7 | RIVPLLV | |
| LaSota Thermolabile strain | 23 | 47 | 1.7 | 25 | IFRIAILFLTVVTLAISVASLLYS |
| 25 | 45 | 2.2a | 21 | FRIAILFLTVVTLAISVASLL | |
| 209 | 210 | 1.7 | 2 | GV | |
| 557 | 563 | 1.7 | 7 | TTIMN | |
| I-2 Thermostable strain | 23 | 44 | 1.7 | 22 | VFRIAILFLTVVTLAVSAAALAYS |
| 25 | 42 | 2.2a | 18 | FRIAILFLTVVTLAVSAAALA | |
| 424 | 429 | 1.7 | 6 | ALLYPM | |
| 557 | 563 | 1.7 | 7 | RIVPLLV | |
| NDV4-C Thermostable | 24 | 44 | 1.7 | 21 | VFRIAILLSTVVTLAISAAAL |
| 25 | 42 | 2.2a | 18 | FRIAILLSTVVTLAISAA | |
| 210 | 210 | 1.7 | 1 | L | |
| 424 | 430 | 1.7 | 7 | ALLYMI | |
| 557 | 563 | 1.7 | 7 | RIVPLLV | |
| NDV TS09-C thermostable | 24 | 44 | 1.7 | 21 | VFRIAILLSTVVTLAISAAAL |
| 25 | 42 | 2.2a | 18 | FRIAILLSTVVTLAISAA | |
| 210 | 211 | 1.7 | 2 | VL | |
| 424 | 430 | 1.7 | 7 | ALLYPMI | |
| 557 | 563 | 1.7 | 7 | RIVPLLV | |
| NDV B1 strain | 24 | 47 | 1.7 | 24 | VFRIAILLSTVVTLAISAAALAYS |
| 25 | 45 | 2.2a | 21 | FRIAILLSTVVTLAISAAALA | |
| 557 | 563 | 1.7 | 7 | RIVPLLV | |
Sequences in boxes show variation in consensus with avirulent strains. The transmembrane domains marked with (a) were significant and considered to different isolates and vaccinates
Sequence identity matrix for CDS of HN gene of thermostable ND-viruses and vaccine strains
| SEQUENCE | LASOTAC5 | TZ | D58 | MU001 | MU007 | MU010 | MU022 | MU039 | MU059 | MU098 | MU111 | LASOTA | I-2 | BEAUDC | C/P/01 | I-2PRO | TS09-C | NDV4C | CLONE30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LA SOTA C5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TZ060107 | 76.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| D58 | 93.5 | 81.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU001 | 76.4 | 85.8 | 81.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU007 | 76.7 | 85.8 | 81.7 | 98.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU010 | 76.7 | 85.8 | 81.7 | 98.3 | 99.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU022 | 76.4 | 85.8 | 81.4 | 99.2 | 98.8 | 98.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU039 | 76.4 | 85.7 | 81.4 | 99.3 | 98.4 | 98.3 | 99.1 |
|
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU059 | 76.6 | 85.9 | 81.6 | 99.0 | 98.5 | 98.4 | 99.3 | 99.0 |
|
|
|
|
|
|
|
|
|
|
|
| NDV/MU098 | 76.4 | 85.8 | 81.4 | 99.0 | 98.6 | 98.4 | 99.3 | 98.9 | 99.0 |
|
|
|
|
|
|
|
|
|
|
| NDV/MU111 | 76.6 | 86.0 | 81.6 | 99.1 | 98.6 | 98.5 | 99.4 | 99.1 | 99.2 | 99.2 |
|
|
|
|
|
|
|
|
|
| LASOTA | 99.7 | 76.2 | 93.6 | 76.3 | 76.6 | 76.6 | 76.3 | 76.3 | 76.5 | 76.3 | 76.5 |
|
|
|
|
|
|
|
|
| I-2 | 87.9 | 78.6 | 82.7 | 77.2 | 77.3 | 77.3 | 77.3 | 77.1 | 77.2 | 77.4 | 77.3 | 87.7 |
|
|
|
|
|
|
|
| BEAUDETTE C | 9.3 | 9.3 | 9.9 | 9.2 | 9.3 | 9.3 | 9.3 | 9.2 | 9.2 | 9.3 | 9.2 | 9.3 | 10.2 |
|
|
|
|
|
|
| C/P/0103/01 | 5.2 | 5.7 | 5.5 | 5.5 | 5.5 | 5.5 | 5.4 | 5.5 | 5.5 | 5.4 | 5.5 | 5.1 | 5.2 | 12.9 |
|
|
|
|
|
| I-2PROGENITOR | 3.0 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 3.0 | 3.0 | 0.2 | 0.6 |
|
|
|
|
| TS09-C | 3.1 | 2.8 | 2.9 | 2.9 | 2.9 | 2.9 | 2.8 | 2.8 | 2.9 | 2.8 | 2.9 | 3.1 | 3.0 | 0.3 | 0.5 | 95.4 |
|
|
|
| NDV4-C | 3.1 | 2.8 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 3.1 | 3.0 | 0.3 | 0.5 | 95.5 | 99.8 |
|
|
| CLONE 30 | 68.5 | 55.0 | 66.8 | 55.1 | 55.2 | 55.2 | 55.0 | 55.1 | 55.1 | 55.2 | 55.2 | 68.5 | 61.4 | 9.0 | 5.0 | 3.2 | 3.1 | 3.1 | ID |
Amino acid differences are indicated in bold and nucleotide differences are in normal font. The difference with commonly used vaccine strains are high lightened
B-cell epitopes of HN gene of representative thermostable field ND-viruses
| HN GENE B-CELL EPITOPES | ||||
|---|---|---|---|---|
| Thermostable field isolates | NDVUG/MU/059 | |||
| NO | Start | End | Peptide | Peptide |
| 1 | 13 | 18 | EEREAK | EEREAK |
| 2 | 48 | 58 | TGASTPSDLAS | GASTPSDLAS |
| 3 | 63 | 69 | ISKAEDR | ISKTEDR |
| 4 | 79 | 79 | E | D |
| 5 | 115 | 135 | NGAANTSGCGAPVHDPDYIGG | NGAANTSGCGAPVHDPDYIGG |
| 6 | 146 | 147 | SD | SD |
| 7 | 150 | 156 | SFYPSAY | SFYPSAY |
| 8 | 164 | 174 | PAPTTGSGCTR | PAPTTGSGCTR |
| 9 | 179 | 180 | DM | DM |
| 10 | 198 | 201 | DHSH | DHSH |
| 11 | 229 | 240 | LDDTQNRKSCSV | LDDTQNRKSCSV |
| 12 | 242 | 244 | ATP | ATP |
| 13 | 255 | 267 | TETEEEDYRSVAP | TETEEEDYRSVAP |
| 14 | 279 | 284 | GQYHEK | GQYHEK |
| 15 | 297 | 307 | ANYPGVGGGSL | ANYPGVGGGSL |
| 16 | 319 | 331 | GLKPNSPSDAAQE | GLKPNSPSDAAQE |
| 17 | 341 | 351 | NNTCPDEQDYQ | NNTCPDEQDYQARMAKSSYKPGRFGGK |
| 18 | 357 | 367 | SSYKPGRFGGK | |
| 19 | 381 | 395 | SLGEDPELTVPPNTV | SLGEDPELTVPPNTV |
| 20 | 418 | 420 | SSY | SSY |
| 21 | 436 | 439 | ATLH | ATLH |
| 22 | 447 | 461 | FTRPGSVPCQASARC | FTRPGSVPCQASARC |
| 23 | 469 | 473 | VYTDP | VYTDP |
| 24 | 494 | 494 | N | N |
| 25 | 496 | 499 | QARL | QARL |
| 26 | 517 | 527 | VSSSSTKAAYT | VSSSSTKAAYT |
A Alanine, R Arginine, N Asparagine, T Threonine, V Valine, C Cysteine, Q Glutamine, E Glutamate, D Aspartate, G Glycine, H Histidine, I Isoleucine, L Leucine, K Lysine, M Methionine, F Phenylalaine, P Proline, S Serine, W Tryptophan, Y Tyrosine
Fig. 4Multiple amino acid sequence alignment of HN proteins. Alignment was performed by dividing amino acids into stabilizing and destabilizing groups. Black bold fonts marked by asterik (*) denote point variation in identity between thermostable and thermolabile viruses